Dr. Reddy's Laboratories reports 14% fall in Q3 consolidated net profit

22 Jan 2026 Evaluate

Dr. Reddy's Laboratories has reported results for third quarter ended December 31, 2025 (Q3FY26). 

The company has reported 89.33% fall in its net profit at Rs 90.60 crore for the third quarter ended December 31, 2025 as compared to Rs 849.40 crore for the same quarter in the previous year. Total income of the company decreased by 11.57% at Rs 4,643.00 crore for Q3FY26 as compared Rs 5,250.40 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 14.42% fall in its net profit at Rs 1,209.90 crore for the third quarter ended December 31, 2025 as compared to Rs 1,413.70 crore for the same quarter in the previous year. However, total income of the company increased by 5.75% at Rs 9,022.20 crore for Q3FY26 as compared Rs 8,531.40 crore for the corresponding quarter previous year.


Dr. Reddys Lab Share Price

1217.15 61.65 (5.34%)
22-Jan-2026 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1374.60
Zydus Lifesciences 883.85
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×